-
Pfizer has selected the University at Buffalo’s Jacobs School of Medicine to be part of an international study of its antiviral drug Paxlovid, and its potential to treat juvenile COVID patients. The oral treatment, which the FDA approved for emergency treatment of adult patients in December 2021, was found to reduce hospitalizations and even fatalities among symptomatic adult COVID patients.
-
As the five counties of Western New York enter Phase Four of reopening Tuesday, Lt. Gov. Kathy Hochul was again urging the public to keep respecting…
-
For years, UB Chemistry Professor John Richard has studied enzymes. Now, he has a new National Institutes of Health grant for $2 million over five years…
-
Around 900 University at Buffalo students participated in a forum addressing opioid addiction at the Jacobs School of Medicine and Biomedical Sciences on…
-
An annual fundraiser for the Foundation Fighting Blindness is expanding. Western New York Vision Walk is now known as WNY VisionFest. Event Coordinator…
-
This is a trick question: You are a college student and don't have much money, so you're faced with a choice between keeping your smartphone operating or…
-
Vitamin D might seem like just another chemical on the long list of vitamins on the side of a multi-vitamin bottle. However, as University at Buffalo…